Indian J Dent Res. 2003 Oct-Dec;14(4):230-3.

Oculodermal melanocytosis--Nevus of Ota (with palatal pigmentation).

Source

Department of Oral Medicine & Radiology, Sree Mookambika Institute of Dental Sciences, Kulasekharam, Kanyakumari District, Tamilnadu--629161.

Abstract

Nevus of Ota is a benign dermal melanocytosis, that involves facial skin as a macular discoloration, appearing as blotchy blue to blue gray. It involves the upper portion of the face, especially over the periorbital area. It also involves ocular structures such as episclera, sclera, conjunctiva, cornea, retina, uveal tract and also nasopharynx, auricular mucosa, tymphanic membrane and dura. Glaucoma and malignant melanoma are the two known ocular complications in patients with Nevus of Ota. 12-18% of these patients exhibits palatal pigmentation. Here we are reporting two cases of Oculodermal melanocytosis, one of which exhibited palatal pigmentation.

PMID:: 15328990; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Case Reports

MeSH Terms

LinkOut - more resources

Medical

Supplemental Content

Save items

Related citations in PubMed

Review [Nevus of Ota. Presentation of a case associated with a cellular blue nevus with suspected malignant degeneration and review of the literature]. [Pathologica. 1997]
Review [Nevus of Ota. Presentation of a case associated with a cellular blue nevus with suspected malignant degeneration and review of the literature].
Bisceglia M, Carosi I, Fania M, Di Ciommo A, Lomuto M. Pathologica. 1997 Apr; 89(2):168-74.
[Nevus of Ota. Apropos of a bilateral case]. [J Fr Ophtalmol. 1983]
[Nevus of Ota. Apropos of a bilateral case].
Desbordes JM, Hamard H. J Fr Ophtalmol. 1983; 6(8-9):715-8.
[Ocular melanocytosis and delayed psycho-intellectual development--other association?]. [Oftalmologia. 2009]
[Ocular melanocytosis and delayed psycho-intellectual development--other association?].
Bivolaru I, Selaru D, Serghiescu I. Oftalmologia. 2009; 53(3):101-4.
Review [Ocular site of pigmentation in oculodermal melanocytosis]. [J Fr Ophtalmol. 1995]
Review [Ocular site of pigmentation in oculodermal melanocytosis].
Oğuz V, Pazarli H, Ocakoğlu O, Ustündağ C, Celikkol L, Oğuz O. J Fr Ophtalmol. 1995; 18(1):40-3.
Review Nevus of Ota in children. [Cutis. 2008]
Review Nevus of Ota in children.
Sinha S, Cohen PJ, Schwartz RA. Cutis. 2008 Jul; 82(1):25-9.

See reviews... See all...

Cited by 2 PubMed Central articles

Nevus of ota with rare palatal involvement: a case report with emphasis on differential diagnosis. [Case Rep Dent. 2011]
Nevus of ota with rare palatal involvement: a case report with emphasis on differential diagnosis.
Sharma G, Nagpal A. Case Rep Dent. 2011; 2011:670679. Epub 2011 Jul 28.
Nevus of ota with buccal mucosal pigmentation: a rare case. [Dent Res J (Isfahan). 2011]
Nevus of ota with buccal mucosal pigmentation: a rare case.
Shetty SR, Subhas BG, Rao KA, Castellino R. Dent Res J (Isfahan). 2011 Winter; 8(1):52-5.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Oculodermal melanocytosis--Nevus of Ota (with palatal pigmentation).
Oculodermal melanocytosis--Nevus of Ota (with palatal pigmentation).
Indian J Dent Res. 2003 Oct-Dec ;14(4):230-3.

PubMed
Managing delegation in the FDA: reducing delay in new-drug review.
Managing delegation in the FDA: reducing delay in new-drug review.
J Health Polit Policy Law. 2004 Jun ;29(3):397-430.

PubMed
Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-in...
Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects.
J Support Oncol. 2004 Mar-Apr ;2(2):111-7; discussion 119-22.

PubMed
Efficacy of an ivermectin/pyrantel pamoate chewable formulation against the cani...
Efficacy of an ivermectin/pyrantel pamoate chewable formulation against the canine hookworms, Uncinaria stenocephala and Ancylostoma caninum.
Vet Parasitol. 1992 Feb ;41(1-2):121-5.

PubMed
The determinants of bronchial hyperresponsiveness in patients with allergic rhin...
The determinants of bronchial hyperresponsiveness in patients with allergic rhinitis.
Ann Allergy Asthma Immunol. 2004 Aug ;93(2):193-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: